|
|
| 6.04 Data as of Apr 17 |  -0.15 / -2.42%Today’s Change | 5.76 Today|||52-Week Range 15.67 | -6.36% Year-to-Date |
| Previous close | 6.19 |
| Today’s open | 6.15 |
| Day’s range | 5.92 - 6.31 |
| Volume | 1,027,202 |
| Average volume (3 months) | 454,724 |
| Market cap | $113.3M |
| Dividend yield | -- |
| Earnings growth (last year) | +33.68% |
| Earnings growth (this year) | -159.37% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.13 |
| Today’s change | Today’s % change | |
|---|---|---|
| ACSTAcasti Pharma Inc | +0.01 | +0.96% |
| ARQLArQule Inc | -0.05 | -2.92% |
| GTXIGTX Inc | -0.04 | -2.94% |
| MDGNMedgenics Inc | 0.00 | 0.00% |
| Next reporting date | May 28, 2014 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.6M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Steven J. Mento |
Chief Financial Officer, Secretary & SVP Charles J. Cashion |
Corporate headquarters San Diego, California |
.
